Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Baleva

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Vutreshni Bolesti|January 1, 1988
[Ischemic heart disease--clinical, biochemical and immunobiological parallels]G Stankusheva, A Chaushev, K Nikolov, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosisB Boyanovsky, M Russeva, V Ganev, et al.
Terapevticheskii Arkhiv|December 8, 2000
[Alpha-2 macroglobulin in serum and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis]Z Kolarov, R Stoilov, M Baleva, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Protein C activity in patients with antiphospholipid syndromeB Boyanovski, M Russeva, G Dobreva, et al.
Akusherstvo I Ginekologiia|January 12, 2002
[Frequency of antiphospholipid antibodies and Leiden mutation of hemostasis Factor V in unexplained recurrent fetal and embryo loss]B Boianovski, M Ruseva, V Ganev, et al.
Annals of the Rheumatic Diseases|September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patientsR Cervera, M A Khamashta, Y Shoenfeld, et al.
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Vutreshni Bolesti|January 1, 1988
[Ischemic heart disease--clinical, biochemical and immunobiological parallels]G Stankusheva, A Chaushev, K Nikolov, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 6, 2001
Prevalence of factor V Leiden and prothrombin 20210 A variant in Bulgarian patients with pulmonary thromboembolism and deep venous thrombosisB Boyanovsky, M Russeva, V Ganev, et al.
Terapevticheskii Arkhiv|December 8, 2000
[Alpha-2 macroglobulin in serum and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis]Z Kolarov, R Stoilov, M Baleva, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Protein C activity in patients with antiphospholipid syndromeB Boyanovski, M Russeva, G Dobreva, et al.
Akusherstvo I Ginekologiia|January 12, 2002
[Frequency of antiphospholipid antibodies and Leiden mutation of hemostasis Factor V in unexplained recurrent fetal and embryo loss]B Boianovski, M Ruseva, V Ganev, et al.
Annals of the Rheumatic Diseases|September 20, 2008
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patientsR Cervera, M A Khamashta, Y Shoenfeld, et al.
Annals of the Rheumatic Diseases|January 28, 2014
Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patientsR Cervera, R Serrano, G J Pons-Estel, et al.
Pageof 3